Related Experiment Video

Updated: Jul 19, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

[Rheumatic diseases as risk factors for cardiovascular disease]

M T Nurmohamed1, A E Voskuyl, I E van der Horst-Bruinsma

  • 1VU Medisch Centrum, afd. Reumatologie, 4A42, Postbus 7057, 1007 MB Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|September 27, 2006
PubMed

Insights

Patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and systemic lupus erythematosus (SLE) face higher cardiovascular disease risks. Inflammation, not just traditional factors, significantly contributes to this increased risk in rheumatic diseases.

Area of Science:

  • Rheumatology and Cardiology
  • Inflammatory and Immune System Diseases

Context:

  • Cardiovascular disease (CVD) is the primary cause of mortality and morbidity in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and systemic lupus erythematosus (SLE).
  • These rheumatic diseases present a significantly elevated cardiovascular risk compared to the general population.

Purpose:

  • To highlight the increased cardiovascular risk associated with RA, AS, and SLE.
  • To emphasize the role of inflammation in exacerbating cardiovascular risk beyond classical risk factors.
  • To call for intervention trials focused on cardiovascular risk reduction in rheumatic disease patients.

Summary:

  • Cardiovascular disease is the leading cause of death in RA, AS, and SLE patients.
  • Increased cardiovascular risk in these conditions is partly due to inflammation, not solely classical risk factors.
  • RA and AS are proposed as new cardiovascular disease risk factors, alongside SLE.

Impact:

  • Recognizing RA, AS, and SLE as cardiovascular disease risk factors is crucial for patient management.
  • Further research and intervention trials are needed to mitigate cardiovascular risks in patients with rheumatic diseases.
  • This understanding can lead to improved patient outcomes and reduced cardiovascular mortality in affected populations.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...